Skip to main content
NCBI home page
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1993 Jan;91(1):141–147. doi: 10.1172/JCI116163

Effect of insulin-like growth factor-1 on the responses to and recognition of hypoglycemia in humans. A comparison with insulin.

D Kerr 1, W V Tamborlane 1, F Rife 1, R S Sherwin 1
PMCID: PMC330007  PMID: 8423214

Abstract

Recombinant human insulin-like growth factor-1 (rhIGF-1) lowers blood glucose in humans but its effect on counterregulatory responses has not been established. We therefore compared infusions of rhIGF-1 (0.7 micrograms/kg per min) and insulin (0.8 mU/kg.min) for 120 min in 10 healthy volunteers (glucose allowed to fall freely). With both, glucose fell rapidly because of stimulation of glucose uptake and suppression of hepatic glucose production. Despite similar plasma glucose nadirs (2.6 +/- 0.1 vs. 2.7 +/- 0.1 mM), the glucagon response was absent (P < 0.005), growth hormone release was attenuated (P < 0.03), and norepinephrine levels were increased (P < 0.05) by rhIGF-1 compared with insulin. Absent glucagon responses were associated with a blunting of the rebound increase in glucose production (P < 0.05 vs. insulin). After stopping the infusions, glucose recovery was delayed with rhIGF-1 (P < 0.001 vs. insulin). To further evaluate the effects of rhIGF-1 during a standard hypoglycemic stimulus, eight additional healthy subjects received rhIGF-1 or insulin while glucose was clamped at 2.8 mM. Again the rise in glucagon during insulin-induced hypoglycemia was totally abolished by rhIGF-1. Growth hormone responses were delayed, whereas increases in norepinephrine, heart rate, and symptomatic awareness of hypoglycemia were greater with rhIGF-1 compared with insulin (P < 0.05). It was concluded that rhIGF-1 suppression of glucagon release during hypoglycemia impairs glucose recovery. Paradoxically, awareness of hypoglycemia is enhanced with rhIGF-1 in part due to stimulation of the sympathetic activity.

Full text

PDF
141

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Abe H., Molitch M. E., Van Wyk J. J., Underwood L. E. Human growth hormone and somatomedin C suppress the spontaneous release of growth hormone in unanesthetized rats. Endocrinology. 1983 Oct;113(4):1319–1324. doi: 10.1210/endo-113-4-1319. [DOI] [PubMed] [Google Scholar]
  2. Amiel S. A., Sherwin R. S., Simonson D. C., Tamborlane W. V. Effect of intensive insulin therapy on glycemic thresholds for counterregulatory hormone release. Diabetes. 1988 Jul;37(7):901–907. doi: 10.2337/diab.37.7.901. [DOI] [PubMed] [Google Scholar]
  3. Amiel S. A., Simonson D. C., Tamborlane W. V., DeFronzo R. A., Sherwin R. S. Rate of glucose fall does not affect counterregulatory hormone responses to hypoglycemia in normal and diabetic humans. Diabetes. 1987 Apr;36(4):518–522. doi: 10.2337/diab.36.4.518. [DOI] [PubMed] [Google Scholar]
  4. Araujo D. M., Lapchak P. A., Collier B., Chabot J. G., Quirion R. Insulin-like growth factor-1 (somatomedin-C) receptors in the rat brain: distribution and interaction with the hippocampal cholinergic system. Brain Res. 1989 Apr 10;484(1-2):130–138. doi: 10.1016/0006-8993(89)90355-7. [DOI] [PubMed] [Google Scholar]
  5. Biggers D. W., Myers S. R., Neal D., Stinson R., Cooper N. B., Jaspan J. B., Williams P. E., Cherrington A. D., Frizzell R. T. Role of brain in counterregulation of insulin-induced hypoglycemia in dogs. Diabetes. 1989 Jan;38(1):7–16. doi: 10.2337/diab.38.1.7. [DOI] [PubMed] [Google Scholar]
  6. Boulware S. D., Tamborlane W. V., Matthews L. S., Sherwin R. S. Diverse effects of insulin-like growth factor I on glucose, lipid, and amino acid metabolism. Am J Physiol. 1992 Jan;262(1 Pt 1):E130–E133. doi: 10.1152/ajpendo.1992.262.1.E130. [DOI] [PubMed] [Google Scholar]
  7. Caro J. F., Poulos J., Ittoop O., Pories W. J., Flickinger E. G., Sinha M. K. Insulin-like growth factor I binding in hepatocytes from human liver, human hepatoma, and normal, regenerating, and fetal rat liver. J Clin Invest. 1988 Apr;81(4):976–981. doi: 10.1172/JCI113451. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Dahmer M. K., Hart P. M., Perlman R. L. Insulin-like growth factor-I enhances tyrosine hydroxylase activation in bovine chromaffin cells. J Neurochem. 1991 Oct;57(4):1347–1353. doi: 10.1111/j.1471-4159.1991.tb08300.x. [DOI] [PubMed] [Google Scholar]
  9. Dahmer M. K., Hart P. M., Perlman R. L. Studies on the effect of insulin-like growth factor-I on catecholamine secretion from chromaffin cells. J Neurochem. 1990 Mar;54(3):931–936. doi: 10.1111/j.1471-4159.1990.tb02340.x. [DOI] [PubMed] [Google Scholar]
  10. Dahmer M. K., Perlman R. L. Bovine chromaffin cells have insulin-like growth factor-I (IGF-I) receptors: IGF-I enhances catecholamine secretion. J Neurochem. 1988 Jul;51(1):321–323. doi: 10.1111/j.1471-4159.1988.tb04873.x. [DOI] [PubMed] [Google Scholar]
  11. Dahmer M. K., Perlman R. L. Insulin and insulin-like growth factors stimulate deoxyribonucleic acid synthesis in PC12 pheochromocytoma cells. Endocrinology. 1988 May;122(5):2109–2113. doi: 10.1210/endo-122-5-2109. [DOI] [PubMed] [Google Scholar]
  12. DeFronzo R. A., Tobin J. D., Andres R. Glucose clamp technique: a method for quantifying insulin secretion and resistance. Am J Physiol. 1979 Sep;237(3):E214–E223. doi: 10.1152/ajpendo.1979.237.3.E214. [DOI] [PubMed] [Google Scholar]
  13. DiCicco-Bloom E., Black I. B. Insulin growth factors regulate the mitotic cycle in cultured rat sympathetic neuroblasts. Proc Natl Acad Sci U S A. 1988 Jun;85(11):4066–4070. doi: 10.1073/pnas.85.11.4066. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Froesch E. R., Schmid C., Schwander J., Zapf J. Actions of insulin-like growth factors. Annu Rev Physiol. 1985;47:443–467. doi: 10.1146/annurev.ph.47.030185.002303. [DOI] [PubMed] [Google Scholar]
  15. Guler H. P., Zapf J., Froesch E. R. Short-term metabolic effects of recombinant human insulin-like growth factor I in healthy adults. N Engl J Med. 1987 Jul 16;317(3):137–140. doi: 10.1056/NEJM198707163170303. [DOI] [PubMed] [Google Scholar]
  16. Guler H. P., Zapf J., Schmid C., Froesch E. R. Insulin-like growth factors I and II in healthy man. Estimations of half-lives and production rates. Acta Endocrinol (Copenh) 1989 Dec;121(6):753–758. doi: 10.1530/acta.0.1210753. [DOI] [PubMed] [Google Scholar]
  17. Havel P. J., Taborsky G. J., Jr The contribution of the autonomic nervous system to changes of glucagon and insulin secretion during hypoglycemic stress. Endocr Rev. 1989 Aug;10(3):332–350. doi: 10.1210/edrv-10-3-332. [DOI] [PubMed] [Google Scholar]
  18. Jacob R. J., Sherwin R. S., Bowen L., Fryburg D., Fagin K. D., Tamborlane W. V., Shulman G. I. Metabolic effects of IGF-I and insulin in spontaneously diabetic BB/w rats. Am J Physiol. 1991 Feb;260(2 Pt 1):E262–E268. doi: 10.1152/ajpendo.1991.260.2.E262. [DOI] [PubMed] [Google Scholar]
  19. Jacob R., Barrett E., Plewe G., Fagin K. D., Sherwin R. S. Acute effects of insulin-like growth factor I on glucose and amino acid metabolism in the awake fasted rat. Comparison with insulin. J Clin Invest. 1989 May;83(5):1717–1723. doi: 10.1172/JCI114072. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Jones T. W., McCarthy G., Tamborlane W. V., Caprio S., Roessler E., Kraemer D., Starick-Zych K., Allison T., Boulware S. D., Sherwin R. S. Mild hypoglycemia and impairment of brain stem and cortical evoked potentials in healthy subjects. Diabetes. 1990 Dec;39(12):1550–1555. doi: 10.2337/diab.39.12.1550. [DOI] [PubMed] [Google Scholar]
  21. Kerr D., Reza M., Smith N., Leatherdale B. A. Importance of insulin in subjective, cognitive, and hormonal responses to hypoglycemia in patients with IDDM. Diabetes. 1991 Aug;40(8):1057–1062. doi: 10.2337/diab.40.8.1057. [DOI] [PubMed] [Google Scholar]
  22. Lieberman S. A., Bukar J., Chen S. A., Celniker A. C., Compton P. G., Cook J., Albu J., Perlman A. J., Hoffman A. R. Effects of recombinant human insulin-like growth factor-I (rhIGF-I) on total and free IGF-I concentrations, IGF-binding proteins, and glycemic response in humans. J Clin Endocrinol Metab. 1992 Jul;75(1):30–36. doi: 10.1210/jcem.75.1.1377706. [DOI] [PubMed] [Google Scholar]
  23. Lund P. K., Moats-Staats B. M., Hynes M. A., Simmons J. G., Jansen M., D'Ercole A. J., Van Wyk J. J. Somatomedin-C/insulin-like growth factor-I and insulin-like growth factor-II mRNAs in rat fetal and adult tissues. J Biol Chem. 1986 Nov 5;261(31):14539–14544. [PubMed] [Google Scholar]
  24. Meuli C., Froesch E. R. Insulin and nonsuppressible insulin-like activity (NSILA-S) stimulate the same glucose transport system via two separate receptors in rat heart. Biochem Biophys Res Commun. 1977 Apr 11;75(3):689–695. doi: 10.1016/0006-291x(77)91527-3. [DOI] [PubMed] [Google Scholar]
  25. Moxley R. T., 3rd, Arner P., Moss A., Skottner A., Fox M., James D., Livingston J. N. Acute effects of insulin-like growth factor I and insulin on glucose metabolism in vivo. Am J Physiol. 1990 Oct;259(4 Pt 1):E561–E567. doi: 10.1152/ajpendo.1990.259.4.E561. [DOI] [PubMed] [Google Scholar]
  26. Philippe J. Glucagon gene transcription is negatively regulated by insulin in a hamster islet cell line. J Clin Invest. 1989 Aug;84(2):672–677. doi: 10.1172/JCI114214. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Poggi C., Le Marchand-Brustel Y., Zapf J., Froesch E. R., Freychet P. Effects and binding of insulin-like growth factor I in the isolated soleus muscle of lean and obese mice: comparison with insulin. Endocrinology. 1979 Sep;105(3):723–730. doi: 10.1210/endo-105-3-723. [DOI] [PubMed] [Google Scholar]
  28. Radziuk J., Norwich K. H., Vranic M. Experimental validation of measurements of glucose turnover in nonsteady state. Am J Physiol. 1978 Jan;234(1):E84–E93. doi: 10.1152/ajpendo.1978.234.1.E84. [DOI] [PubMed] [Google Scholar]
  29. Ross R. J., Miell J. P., Buchanan C. R. Avoiding autocannibalism. BMJ. 1991 Nov 9;303(6811):1147–1148. doi: 10.1136/bmj.303.6811.1147. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Sara V. R., Carlsson-Skwirut C., Andersson C., Hall E., Sjögren B., Holmgren A., Jörnvall H. Characterization of somatomedins from human fetal brain: identification of a variant form of insulin-like growth factor I. Proc Natl Acad Sci U S A. 1986 Jul;83(13):4904–4907. doi: 10.1073/pnas.83.13.4904. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Sara V. R., Hall K. Insulin-like growth factors and their binding proteins. Physiol Rev. 1990 Jul;70(3):591–614. doi: 10.1152/physrev.1990.70.3.591. [DOI] [PubMed] [Google Scholar]
  32. Van Schravendijk C. F., Foriers A., Van den Brande J. L., Pipeleers D. G. Evidence for the presence of type I insulin-like growth factor receptors on rat pancreatic A and B cells. Endocrinology. 1987 Nov;121(5):1784–1788. doi: 10.1210/endo-121-5-1784. [DOI] [PubMed] [Google Scholar]
  33. Van Schravendijk C. F., Heylen L., Van den Brande J. L., Pipeleers D. G. Direct effect of insulin and insulin-like growth factor-I on the secretory activity of rat pancreatic beta cells. Diabetologia. 1990 Nov;33(11):649–653. doi: 10.1007/BF00400565. [DOI] [PubMed] [Google Scholar]
  34. Vetter U., Kupferschmid C., Lang D., Pentz S. Insulin-like growth factors and insulin increase the contractility of neonatal rat cardiocytes in vitro. Basic Res Cardiol. 1988 Nov-Dec;83(6):647–654. doi: 10.1007/BF01906959. [DOI] [PubMed] [Google Scholar]
  35. Walker J. L., Ginalska-Malinowska M., Romer T. E., Pucilowska J. B., Underwood L. E. Effects of the infusion of insulin-like growth factor I in a child with growth hormone insensitivity syndrome (Laron dwarfism). N Engl J Med. 1991 May 23;324(21):1483–1488. doi: 10.1056/NEJM199105233242107. [DOI] [PubMed] [Google Scholar]
  36. Weir G. C., Knowlton S. D., Martin D. B. Glucagon secretion from the perfused rat pancreas. Studies with glucose and catecholamines. J Clin Invest. 1974 Dec;54(6):1403–1412. doi: 10.1172/JCI107887. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES